Pages that link to "Q38426254"
Jump to navigation
Jump to search
The following pages link to Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers (Q38426254):
Displaying 50 items.
- Enhancing vaccine safety capacity globally: A lifecycle perspective (Q26782451) (← links)
- Roads to the development of improved pertussis vaccines paved by immunology (Q26782939) (← links)
- Experience with monocomponent acellular pertussis combination vaccines for infants, children, adolescents and adults--a review of safety, immunogenicity, efficacy and effectiveness studies and 15 years of field experience (Q26822908) (← links)
- Old Disease and New Challenges: Major Obstacles of Current Strategies in the Prevention of Pertussis (Q27691413) (← links)
- A population response analysis approach to assign class II HLA-epitope restrictions (Q28395866) (← links)
- Using Spatial Analysis to Inform Community Immunization Strategies (Q30234578) (← links)
- Prevalence of Atypical Pathogens in Patients With Cough and Community-Acquired Pneumonia: A Meta-Analysis (Q30234952) (← links)
- Highlights of the 11th International Bordetella Symposium: from Basic Biology to Vaccine Development (Q30245164) (← links)
- Vaccination in elite athletes (Q34227424) (← links)
- Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model (Q34387963) (← links)
- Safety and immunogenicity of tetanus diphtheria and acellular pertussis (Tdap) immunization during pregnancy in mothers and infants: a randomized clinical trial (Q35097262) (← links)
- Pertussis. A reemerging and an underreported infectious disease. (Q35183514) (← links)
- Pertussis outbreak, southeastern Minnesota, 2012. (Q35456030) (← links)
- Identification of pertussis-specific effector memory T cells in preschool children (Q35548052) (← links)
- A comparative clinical study to assess safety and reactogenicity of a DTwP-HepB+Hib vaccine. (Q35886986) (← links)
- Kaiser Permanente Vaccine Study Center: Highlights of 2009-2012. (Q35890630) (← links)
- Characterization of the immune response induced by pertussis OMVs-based vaccine (Q36010403) (← links)
- Comparative Epidemiologic Characteristics of Pertussis in 10 Central and Eastern European Countries, 2000-2013. (Q36039358) (← links)
- Strategies and new developments to control pertussis, an actual health problem (Q36226470) (← links)
- Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study (Q36256344) (← links)
- Comparison of Three Whole-Cell Pertussis Vaccines in the Baboon Model of Pertussis (Q36457650) (← links)
- Development of improved pertussis vaccine (Q36978320) (← links)
- Licensed pertussis vaccines in the United States. History and current state (Q37154787) (← links)
- Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Perú, 2012 (Q37182380) (← links)
- Effectiveness of pertussis vaccination and duration of immunity. (Q37382056) (← links)
- Factors influencing the spread of pertussis in households: a prospective study, Catalonia and Navarre, Spain, 2012 to 2013. (Q37485438) (← links)
- Antibody responses to Bordetella pertussis Fim2 or Fim3 following immunization with a whole-cell, two-component, or five-component acellular pertussis vaccine and following pertussis disease in children in Sweden in 1997 and 2007. (Q37545016) (← links)
- Vaccination in the elderly: what can be recommended? (Q38220158) (← links)
- Adult pertussis in the pre- and post-vaccine eras: lifelong vaccine-induced immunity? (Q38225351) (← links)
- Waning vaccine immunity in teenagers primed with whole cell and acellular pertussis vaccine: recent epidemiology (Q38237077) (← links)
- Pertussis in Latin America: epidemiology and control strategies (Q38241405) (← links)
- The baboon model of pertussis: effective use and lessons for pertussis vaccines (Q38245642) (← links)
- Control selection methods in recent case-control studies conducted as part of infectious disease outbreaks. (Q38374434) (← links)
- Waning protection following 5 doses of a 3-component diphtheria, tetanus, and acellular pertussis vaccine (Q38400982) (← links)
- T-cell immune responses to Bordetella pertussis infection and vaccination. (Q38560699) (← links)
- Immune persistence after pertussis vaccination (Q38775297) (← links)
- Surveillance of Vaccination Coverage among Adult Populations - United States, 2015. (Q38804622) (← links)
- Pertussis: History of the Disease and Current Prevention Failure (Q38852136) (← links)
- Changing from whole-cell to acellular pertussis vaccines would trade superior tolerability for inferior protection (Q39065890) (← links)
- Reining in the "100-day cough": unfinished business (Q39348063) (← links)
- Immunization Update VI. (Q39422592) (← links)
- The Pertussis resurgence: putting together the pieces of the puzzle (Q40061323) (← links)
- Parental weighting of seizure risks vs. fever risks in vaccination tradeoff decisions (Q40081048) (← links)
- What Is Wrong with Pertussis Vaccine Immunity? The Problem of Waning Effectiveness of Pertussis Vaccines (Q40295958) (← links)
- What Is Wrong with Pertussis Vaccine Immunity? Inducing and Recalling Vaccine-Specific Immunity (Q40295972) (← links)
- Outer membrane vesicles: an attractive candidate for pertussis vaccines (Q40410058) (← links)
- Whooping cough in a renal transplant recipient. (Q40818810) (← links)
- Reduced risk of pertussis in whole-cell compared to acellular vaccine recipients is not confounded by age or receipt of booster-doses (Q41038468) (← links)
- Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage (Q41707535) (← links)
- Estimating the effectiveness of tetanus-diphtheria-acellular pertussis vaccine (Tdap) for preventing pertussis: evidence of rapidly waning immunity and difference in effectiveness by Tdap brand (Q42211885) (← links)